About BTB Therapeutics
BTB Therapeutics is a private company based in Escondido, California, incorporated in 2024 in Delaware. It has reported $8,902,204 raised in one offering on Form D since December 2025. Its chief executive is Takashi Kiyoizumi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Dec 1, 2025amended Aug 12, 2026 | $8,902,204of $10.4M target | 4 | $2.2M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BTB Therapeutics's Form D filed Aug 12, 2026.
